October 7, 2008 - VisualSonics launched the Vevo 2100 preclinical imaging platform in North America and Europe, designed to produce first high-resolution images with edge-to-edge clarity and dynamic focusing are possible and will allow small animal researchers to scan measure and quantify with ease.
The system provides color doppler, strain analysis and reportedly high-field of view clarity. Acccording to the manufacturer, the Vevo 2100 represents a breakthrough in imaging technology by including color flow imaging, advanced transducers and a robust analysis package.
Noninvasive, real-time in vivo imaging with high resolution has defined VisualSonics contribution to small animal microimaging. Innovation has continued with the Vevo 2100.
The Vevo 2100 provides researchers the flexibility to conduct longitudinal studies on a range of models, including the mouse, rat, zebra fish and rabbit. These models play an important role in translating research from the laboratory to the clinic.
For more information: www.visualsonics.com
March 13, 2026 
